Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 16.1519.1713.5429.1926.12

What is the latest EV/Core EBITDA ratio of GLAND PHARMA ?

The latest EV/Core EBITDA ratio of GLAND PHARMA is 16.15 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202516.15
Mar202419.17
Mar202313.54
Mar202229.19
Mar202126.12

How is EV/Core EBITDA of GLAND PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 16.15
-15.75
Mar2024 19.17
41.58
Mar2023 13.54
-53.61
Mar2022 29.19
11.75
Mar2021 26.12 -

Other Financial Ratios of GLAND PHARMA


Compare EV/Core EBITDA ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹35,583.6 Cr 15.3% 24.4% 30.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,121.0 Cr 3.2% 12.5% 10.6% Stock Analytics
DIVIS LABORATORIES ₹181,396.0 Cr 2.9% 8.5% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,730.0 Cr 0.3% 5.7% 36.3% Stock Analytics
CIPLA ₹115,241.0 Cr 10.4% 15.9% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹111,126.0 Cr 4.8% 9% 10.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

15.3%

24.4%

30.2%

SENSEX

-0.9%

-3.6%

-8.6%


You may also like the below Video Courses